Skip navigation
Skip to main content

Browsing by Subject type 2 diabetes

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:  
Showing results 1 to 10 of 10
PreviewIssue DateTitleAuthor(s)
Jul-2013Adapting and validating diabetes simulation models across settings: Accounting for mortality differences using administrative dataHayes, Alison; Davis, Wendy; Davis, Tim; Clarke, Philip
Feb-2012Effects of fenofibrate on cardiovascular events in patients with diabetes, with and without prior cardiovascular disease: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) studyTonkin, Andrew; Hunt, David; Voysey, Merryn; Kesäniemi, Antero; Hamer, Andrew; Waites, Jonathon; Maher, Leo; Mann, Stewart; Glasziou, Paul; Forder, Peta; Simes, John; Keech, Anthony
23-Aug-2014Favourable effects of fenofibrate on lipids and cardiovascular disease in women with type 2 diabetes: results from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) studyD'Emden, Michael C; Jenkins, Alicia J; Li, Liping; Zannino, Diana; Mann, Kristy P; Best, James D; Stuckey, Bronwyn GA; Park, Kris; Saltevo, Juha; Keech, Anthony C
4-Oct-2015Low alanine aminotransferase levels and higher number of cardiovascular events in people with type 2 diabetes: analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) studyWilliams, KH; Sullivan, DR; Veillard, AS; O'Brien, R; George, J; Jenkins, AJ; Young, S; Ehnholm, C; Duffield, A; Twigg, SM; Keech, AC
2012Omega-3 Fatty Acids and incident Type 2 Diabetes A Systematic Review and Meta-AnalysisWu, Jason Hao Yu
31-Aug-2017Probiotics in the prevention and management of obesity and type 2 diabetes mellitusPalacios Campaña, Talia
20-Oct-2012Rates and predictors of risk of stroke and its subtypes in diabetes: a prospective observational studyHankey, Graeme J; Anderson, Neil E; Ting Ru-Dee; Veillard, Anne-Sophie; Romo, Matti; Wosik, Melinda; Sullivan, David R; O'Connell, Rachel L; Hunt, David; Keech, Anthony C
26-Nov-2014The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes studyOng, Kwok-Leung; Januszewski, Andrzej S; O'Connell, Rachel; Jenkins, Alicia J; Xu, Aimin; Sullivan, David R; Barter, Philip J; Hung, Wei-Ting; Scott, Russell S; Taskinen, Marja-Riitta; Keech, Anthony C; Rye, Kerry-Anne
20-Dec-2014Serum 25-hydroxy vitamin D: a predictor of macrovascular and microvascular complications in patients with type 2 diabetesHerrman, Markus; Sullivan, David R; Veillard, Anne-Sophie; McCorquodale, Thomas; Straub, Isabella R; Scott, Russell; Laakso, Markku; Topliss, Duncan; Jenkins, Alicia J; Blankenberg, Stefan; Burton, Anthony; Keech, Anthony C
30-Dec-2015Targeting non-alcoholic steatohepatitis induced by high fat feeding and type 2 diabetes in a preclinical modelRen, Jing